May 27th, 2016
•This protocol describes the feasibility to perform miRNA profiling in exosomes, released in plasma of NSCLC patients, through a commercial exosome isolation kit with Proteinase K and RNAse treatments, in order to avoid circulating miRNAs contamination and evaluate their biomarker features in NSCLC.
Videos relacionados
Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
A Simple Method of Mouse Lung Intubation
A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados